Nemaura Medical (NASDAQ: NMRD)
Some price data may be temporarily unavailable.
Nemaura Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Nemaura Medical Company Info
Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.
News & Analysis
Why Micro Cap Nemaura Medical Crashed 39.5% Today
The clinical-stage upstart is raising money via a stock offering that dilutes existing investors.
Why Micro Cap Nemaura Medical Skyrocketed 32% Yesterday
The clinical-stage upstart is making progress in advancing a new type of glucose monitor to market.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.